eMed Technologies

eMed Technologies, founded in 2015 and headquartered in Cambridge, Massachusetts, is a private company specializing in advanced subcutaneous infusion systems for home-based care. Its core business model combines the development of proprietary drug delivery devices with comprehensive services for pharmaceutical partners, positioning it in the high-growth digital health and diagnostics sector. The company is commercial, generating revenue through its products and services, and targets the expanding market for biologics and at-home infusion therapies. Its strategy centers on enhancing treatment adherence, patient comfort, and quality of care through user-centric design.

Platform for advanced subcutaneous infusion systems, including wearable devices, disposables, and digital tools for patient education and infusion optimization, designed for biologics and specialty drugs.

eMed competes in the subcutaneous drug delivery market against large, diversified medtech companies like BD, Insulet, and Ypsomed, as well as smaller specialized firms. Its differentiation lies in its end-to-end service model and focus on patient-centric design for home infusion, but it must contend with competitors' greater scale, broader portfolios, and established sales channels.